{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T17:13:22Z","timestamp":1770830002386,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:00:00Z","timestamp":1689811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Myasthenia gravis (MG) is an autoimmune disease characterized by weakness and rapid fatigue. Diagnostic methods used for myasthenia gravis are not conclusive and satisfactory, therefore it is necessary to develop reliable tools to help diagnose myasthenia gravis as early as possible. The aim of the study was to use HPLC\u2013MS in conjunction with multivariate statistical analyses to investigate changes in the amino acid metabolic profiles between myasthenia gravis patients compared and controls. In addition, the effect of treatment regimens and myasthenia gravis type, on the observed changes in amino acid metabolic profiles were assessed. Serum levels of 29 amino acids were determined in 2 groups of individuals\u201428 patients with myasthenia gravis and 53 control subjects (CS). The results of our study indicate that serum levels of several amino acids in patients with myasthenia gravis changed significantly compared to the control group. Statistical analysis revealed differences between amino acids concentration in patients with different therapeutic scheme. In conclusion, amino acids may be involved in mechanisms underlying myasthenia gravis pathogenesis as well as may be potential biomarkers in MG patients diagnosis. However, considering the multifactorial, heterogenous and complex nature of this disease, validation on a larger study sample in further research is required before application into diagnostic practice.<\/jats:p>","DOI":"10.1007\/s00726-023-03303-3","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T18:03:33Z","timestamp":1689876213000},"page":"1157-1172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serum amino acid profiles in patients with myasthenia gravis"],"prefix":"10.1007","volume":"55","author":[{"given":"Piotr","family":"Ko\u015bli\u0144ski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0141ukasz","family":"Rzepi\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Daghir-Wojtkowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Koba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zdzis\u0142aw","family":"Maciejek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,20]]},"reference":[{"key":"3303_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2013.12.011","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Le Panse R (2014) Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. J Autoimmun. https:\/\/doi.org\/10.1016\/j.jaut.2013.12.011","journal-title":"J Autoimmun"},{"key":"3303_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","volume":"48\u201349","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B (2014) Diagnostic and clinical classification of autoimmune myasthenia gravis. J Autoimmun 48\u201349:143\u2013148. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.003","journal-title":"J Autoimmun"},{"key":"3303_CR3","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-019-1571-9","author":"D Blackmore","year":"2019","unstructured":"Blackmore D, Siddiqi Z, Li L, Wang N, Maksymowych W (2019) Beyond the antibodies: serum metabolomic profiling of myasthenia gravis. Metabolomics. https:\/\/doi.org\/10.1007\/s11306-019-1571-9","journal-title":"Metabolomics"},{"key":"3303_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1159\/000466688","volume":"7","author":"G Corso","year":"2017","unstructured":"Corso G, Cristofano A, Sapere N, La Marca G, Angiolillo A, Vitale M, Fratangelo R, Lombardi T, Porcile C, Intrieri M, Di Costanzo A (2017) Serum amino acid profiles in normal subjects and in patients with or at risk of Alzheimer dementia. Dement Geriatr Cogn Dis Extra 7:143\u2013159. https:\/\/doi.org\/10.1159\/000466688","journal-title":"Dement Geriatr Cogn Dis Extra"},{"key":"3303_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/nu10111564","author":"V Cruzat","year":"2018","unstructured":"Cruzat V, Rogero MM, Keane KN, Curi R, Newsholme P (2018) Glutamine: metabolism and immune function, supplementation and clinical translation. Nutrients. https:\/\/doi.org\/10.3390\/nu10111564","journal-title":"Nutrients"},{"key":"3303_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112235","author":"L Dresser","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B (2021) Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. https:\/\/doi.org\/10.3390\/jcm10112235","journal-title":"J Clin Med"},{"key":"3303_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0191670","author":"M Figura","year":"2018","unstructured":"Figura M, Ku\u015bmierska K, Bucior E, Szlufik S, Koziorowski D, Jamrozik Z, Janik P (2018) Serum amino acid profile in patients with Parkinson\u2019s disease. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0191670","journal-title":"PLoS ONE"},{"key":"3303_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2012.01.009","author":"G Hassan-Smith","year":"2012","unstructured":"Hassan-Smith G, Wallace GR, Douglas MR, Sinclair AJ (2012) The role of metabolomics in neurological disease. J Neuroimmunol. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.01.009","journal-title":"J Neuroimmunol"},{"key":"3303_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/nu12030848","author":"M Hole\u010dek","year":"2020","unstructured":"Hole\u010dek M (2020) Histidine in health and disease: Metabolism, physiological importance, and use as a supplement. Nutrients. https:\/\/doi.org\/10.3390\/nu12030848","journal-title":"Nutrients"},{"key":"3303_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.1057709","author":"MN Iman","year":"2022","unstructured":"Iman MN, Herawati E, Fukusaki E, Putri SP (2022) Metabolomics-driven strain improvement: a mini review. Front Mol Biosci. https:\/\/doi.org\/10.3389\/fmolb.2022.1057709","journal-title":"Front Mol Biosci"},{"key":"3303_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/npp.2008.174","author":"R Kaddurah-Daouk","year":"2009","unstructured":"Kaddurah-Daouk R, Krishnan KRR (2009) Metabolomics: a global biochemical approach to the study of central nervous system diseases. Neuropsychopharmacology. https:\/\/doi.org\/10.1038\/npp.2008.174","journal-title":"Neuropsychopharmacology"},{"key":"3303_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1749-6632.2012.06787.x","volume":"1275","author":"HJ Kaminski","year":"2012","unstructured":"Kaminski HJ, Kusner LL, Wolfe GI, Aban I, Minisman G, Conwit R, Cutter G (2012) Biomarker development for myasthenia gravis. Ann N Y Acad Sci 1275:101\u2013106. https:\/\/doi.org\/10.1111\/j.1749-6632.2012.06787.x","journal-title":"Ann N Y Acad Sci"},{"key":"3303_CR13","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.4049\/jimmunol.1301859","volume":"192","author":"H Kato","year":"2014","unstructured":"Kato H, Perl A (2014) Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4\u2212CD8\u2212 double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus. J Immunol 192:4134\u20134144. https:\/\/doi.org\/10.4049\/jimmunol.1301859","journal-title":"J Immunol"},{"key":"3303_CR14","doi-asserted-by":"publisher","DOI":"10.4155\/bio-2016-0090","author":"I Kohler","year":"2016","unstructured":"Kohler I, Verhoeven A, Derks RJ, Giera M (2016) Analytical pitfalls and challenges in clinical metabolomics. Bioanalysis. https:\/\/doi.org\/10.4155\/bio-2016-0090","journal-title":"Bioanalysis"},{"key":"3303_CR15","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1073\/pnas.1714717115","volume":"115","author":"M Kono","year":"2018","unstructured":"Kono M, Yoshida N, Maeda K, Tsokos GC (2018) Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells. Proc Natl Acad Sci U S A 115:2478\u20132483. https:\/\/doi.org\/10.1073\/pnas.1714717115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3303_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.623844","author":"M Kono","year":"2021","unstructured":"Kono M, Yoshida N, Tsokos GC (2021) Amino acid metabolism in lupus. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2021.623844","journal-title":"Front Immunol"},{"key":"3303_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-0375-3","author":"EL Lieu","year":"2020","unstructured":"Lieu EL, Nguyen T, Rhyne S, Kim J (2020) Amino acids in cancer. Exp Mol Med. https:\/\/doi.org\/10.1038\/s12276-020-0375-3","journal-title":"Exp Mol Med"},{"key":"3303_CR18","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1007\/s11306-011-0364-6","volume":"8","author":"Y Lu","year":"2012","unstructured":"Lu Y, Wang C, Chen Z, Zhao H, Chen J, Liu X, Kwan Y, Lin H, Ngai S (2012) Serum metabolomics for the diagnosis and classification of myasthenia gravis. Metabolomics 8:704\u2013713. https:\/\/doi.org\/10.1007\/s11306-011-0364-6","journal-title":"Metabolomics"},{"key":"3303_CR19","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/aje\/152.8.752","volume":"152","author":"T Myint","year":"2000","unstructured":"Myint T, Fraser GE, Lindsted KD, Knutsen SF, Hubbard RW, Bennett HW (2000) Urinary 1-methylhistidine is a marker of meat consumption in black and in white California seventh-day adventists. Am J Epidemiol 152:752\u2013755","journal-title":"Am J Epidemiol"},{"key":"3303_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1271\/bbb.60.501","volume":"60","author":"T Nagasawa","year":"1996","unstructured":"Nagasawa T, Yoshizawa F, Nishizawa N (1996) NII-electronic library service plasma N!-methylhistidine concentration is a sensitive index of myofibrillar protein degradation during starvation in rats. Biosci Biotechnol Biochem 60:501\u2013502","journal-title":"Biosci Biotechnol Biochem"},{"key":"3303_CR21","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S0165-5728(02)00037-1","volume":"125","author":"F Sellebjerg","year":"2002","unstructured":"Sellebjerg F, Giovannoni G, Hand A, Madsen HO, Jensen CV, Garred P (2002) Cerebrospinal fluid levels of nitric oxide metabolites predict response to methylprednisolone treatment in multiple sclerosis and optic neuritis. J Neuroimmunol 125:198\u2013203","journal-title":"J Neuroimmunol"},{"key":"3303_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102635","author":"M Sengupta","year":"2014","unstructured":"Sengupta M, Cheema A, Kaminski HJ, Kusner LL (2014a) Serum metabolomic response of myasthenia gravis patients to chronic prednisone treatment. PLoS ONE. https:\/\/doi.org\/10.1371\/journal.pone.0102635","journal-title":"PLoS ONE"},{"key":"3303_CR23","unstructured":"Shearer JD, Richards JR, Mills CD, Caldwell MD (2018) Downloaded from www.physiology.org\/journal\/ajpendo by ${individualUser"},{"key":"3303_CR24","unstructured":"Sjijlin J, Hjort G, Friman G, Hambraeus L (1987) Urinary excretion of l-methylhistidine: a qualitative indicator of exogenous 3-methylhistidine and intake of meats from various sources"},{"key":"3303_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00726-019-02705-6","author":"E Socha","year":"2019","unstructured":"Socha E, Koba M, Ko\u015bli\u0144ski P (2019) Amino acid profiling as a method of discovering biomarkers for diagnosis of neurodegenerative diseases. Amino Acids. https:\/\/doi.org\/10.1007\/s00726-019-02705-6","journal-title":"Amino Acids"},{"key":"3303_CR26","doi-asserted-by":"publisher","first-page":"4147","DOI":"10.4049\/jimmunol.169.8.4147","volume":"169","author":"K Tenbrock","year":"2002","unstructured":"Tenbrock K, Juang Y-T, Gourley MF, Nambiar MP, Tsokos GC (2002) Antisense cyclic adenosine 5\u2032-monophosphate response element modulator up-regulates IL-2 in T cells from patients with systemic lupus erythematosus. J Immunol 169:4147\u20134152. https:\/\/doi.org\/10.4049\/jimmunol.169.8.4147","journal-title":"J Immunol"},{"key":"3303_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/mus.880040111","volume":"4","author":"DM Warnes","year":"1981","unstructured":"Warnes DM, Thomas FM, John-Ballard F (1981) Increased rates of myofibrillar protein breakdown in muscle=wasting diseases. Muscle Nerve 4:62\u201366","journal-title":"Muscle Nerve"},{"key":"3303_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2020.593431","author":"Y Wu","year":"2020","unstructured":"Wu Y, Luo J, Garden OA (2020) Immunoregulatory cells in myasthenia gravis. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2020.593431","journal-title":"Front Neurol"},{"key":"3303_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms12993","author":"N Yoshida","year":"2016","unstructured":"Yoshida N, Comte D, Mizui M, Otomo K, Rosetti F, Mayadas TN, Crisp\u00edn JC, Bradley SJ, Koga T, Kono M, Karampetsou MP, Kyttaris VC, Tenbrock K, Tsokos GC (2016) ICER is requisite for Th17 differentiation. Nat Commun. https:\/\/doi.org\/10.1038\/ncomms12993","journal-title":"Nat Commun"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-023-03303-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00726-023-03303-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-023-03303-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T10:06:15Z","timestamp":1696932375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00726-023-03303-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,20]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["3303"],"URL":"https:\/\/doi.org\/10.1007\/s00726-023-03303-3","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,20]]},"assertion":[{"value":"23 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Bioethics Committee of the Nicolaus Copernicus University in Toru\u0144 functioning at Collegium Medicum in Bydgoszcz reviewed and approved this study, and written informed consent was required from the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed Consent Form, Patient Survey Form and Investigator Survey Form were also reviewed and approved by the Bioethics Committee. Written informed consent forms have been obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}}]}}